Red digital : revista de tecnologías de la información y comunicación educativas

El grupo Salzillo de profesores del Departamento de Dibujo del IES Francisco Salzillo de Alcantarilla describe los contenidos pedagógicos, estratégicos y temáticos desarrollados en la asignatura de Comunicación Audiovisual. La comprensión del mundo de la imagen en los aspectos técnico y expresivo, el análisis cinematográfico y la práctica y experimentación a través del uso de la cámara, son objetivos que se desarrollan durante la ejecución de ejercicios. De menor a mayor dificultad y complejidad estos son: la entrevista, el videoclip, el spot publicitario, las copias de escenas de cine, la animación, el reportaje y el cortometraje. El duro trabajo y el empeño puestos a lo largo del curso, se ven premiados y recompensados con el aplauso del público en la Gran Gala de la Imagen.MadridES

La política cultural de la Región de Murcia en tiempos de crisis (2007-2010)

Análisis de la situación cultural de la Región de Murcia en sus distintos ámbitos (artes escénicas, archivos, bibliotecas y museos, artes visuales, lectura, prácticas culturales...) y su relación con las políticas públicas de cultura desarrolladas en los últimos cuatro años (2007-2010),partiendo de sus antecedentes y el contexto en que se inscriben

Enhanced oxidative stress and other potential biomarkers for retinopathy in type 2 diabetics: beneficial effects of the nutraceutic supplements

We have studied the global risk of retinopathy in a Mediterranean population of type 2 diabetes mellitus (T2DM) patients, according to clinical, biochemical, and lifestyle biomarkers. The effects of the oral supplementation containing antioxidants/omega 3 fatty acids (A/ω3) were also evaluated. Suitable participants were distributed into two main groups: (1) T2DMG (with retinopathy (+DR) or without retinopathy (-DR)) and (2) controls (CG). Participants were randomly assigned (+A/ω3) or not (-A/ω3) to the oral supplementation with a daily pill of Nutrof Omega (R) for 18 months. Data collected including demographics, anthropometrics, characteristics/lifestyle, ophthalmic examination (best corrected visual acuity, ocular fundus photographs, and retinal thickness as assessed by optical coherence tomography), and blood parameters (glucose, glycosylated hemoglobin, triglycerides, malondialdehyde, and total antioxidant capacity) were registered, integrated, and statistically processed by the SPSS 15.0 program. Finally, 208 participants (130 diabetics (68 +DR/62 -DR) and 78 controls) completed the follow-up. Blood analyses confirmed that the T2DMG+DR patients had significantly higher oxidative stress (p < 0.05), inflammatory (p < 0.05), and vascular (p < 0.001) risk markers than the T2DMG-DR and the CG. Furthermore, the A/ω3 oral supplementation positively changed the baseline parameters, presumptively by inducing metabolic activation and ameliorating the ocular health after 18 months of supplementation

Aplicaciones educativas de la psicología positiva

Resumen basado en el de la publicaciónSe realiza un acercamiento a la psicología positiva, desde el estudio de las bases de bienestar psicológico, la felicidad, las fortalezas y virtudes humanas. La psicología positiva promueve el estudio de las características, condiciones y procesos que contribuyen al funcionamiento óptimo de la persona, a su excelencia como individuo y al logro de una vida plena y significativa. Se tratan temas como el trabajo en equipo, la creatividad, el liderazgo, la resolución de problemas, las relaciones interpersonales, el optimismo, etc. Se considera que la aplicación a la escuela de esta corriente dentro de la psicología es necesaria. Por lo tanto, se apuesta por una tarea educativa entendida como recurso cultural de gestión personal de conocimiento para saber y ser feliz en la vida.ValenciaBiblioteca de Educación del Ministerio de Educación, Cultura y Deporte; Calle San Agustín, 5 - 3 planta; 28014 Madrid; Tel. +34917748000; [email protected]

Aplicaciones educativas de la psicología positiva

Resumen basado en el de la publicaciónSe realiza un acercamiento a la psicología positiva, desde el estudio de las bases de bienestar psicológico, la felicidad, las fortalezas y virtudes humanas. La psicología positiva promueve el estudio de las características, condiciones y procesos que contribuyen al funcionamiento óptimo de la persona, a su excelencia como individuo y al logro de una vida plena y significativa. Se tratan temas como el trabajo en equipo, la creatividad, el liderazgo, la resolución de problemas, las relaciones interpersonales, el optimismo, etc. Se considera que la aplicación a la escuela de esta corriente dentro de la psicología es necesaria. Por lo tanto, se apuesta por una tarea educativa entendida como recurso cultural de gestión personal de conocimiento para saber y ser feliz en la vida.ValenciaBiblioteca de Educación del Ministerio de Educación, Cultura y Deporte; Calle San Agustín, 5 - 3 planta; 28014 Madrid; Tel. +34917748000; [email protected]

Risk of COVID-19 after natural infection or vaccinationResearch in context

Summary: Background: While vaccines have established utility against COVID-19, phase 3 efficacy studies have generally not comprehensively evaluated protection provided by previous infection or hybrid immunity (previous infection plus vaccination). Individual patient data from US government-supported harmonized vaccine trials provide an unprecedented sample population to address this issue. We characterized the protective efficacy of previous SARS-CoV-2 infection and hybrid immunity against COVID-19 early in the pandemic over three-to six-month follow-up and compared with vaccine-associated protection. Methods: In this post-hoc cross-protocol analysis of the Moderna, AstraZeneca, Janssen, and Novavax COVID-19 vaccine clinical trials, we allocated participants into four groups based on previous-infection status at enrolment and treatment: no previous infection/placebo; previous infection/placebo; no previous infection/vaccine; and previous infection/vaccine. The main outcome was RT-PCR-confirmed COVID-19 >7–15 days (per original protocols) after final study injection. We calculated crude and adjusted efficacy measures. Findings: Previous infection/placebo participants had a 92% decreased risk of future COVID-19 compared to no previous infection/placebo participants (overall hazard ratio [HR] ratio: 0.08; 95% CI: 0.05–0.13). Among single-dose Janssen participants, hybrid immunity conferred greater protection than vaccine alone (HR: 0.03; 95% CI: 0.01–0.10). Too few infections were observed to draw statistical inferences comparing hybrid immunity to vaccine alone for other trials. Vaccination, previous infection, and hybrid immunity all provided near-complete protection against severe disease. Interpretation: Previous infection, any hybrid immunity, and two-dose vaccination all provided substantial protection against symptomatic and severe COVID-19 through the early Delta period. Thus, as a surrogate for natural infection, vaccination remains the safest approach to protection. Funding: National Institutes of Health

Risk of COVID-19 after natural infection or vaccinationResearch in context

Background: While vaccines have established utility against COVID-19, phase 3 efficacy studies have generally not comprehensively evaluated protection provided by previous infection or hybrid immunity (previous infection plus vaccination). Individual patient data from US government-supported harmonized vaccine trials provide an unprecedented sample population to address this issue. We characterized the protective efficacy of previous SARS-CoV-2 infection and hybrid immunity against COVID-19 early in the pandemic over three-to six-month follow-up and compared with vaccine-associated protection. Methods: In this post-hoc cross-protocol analysis of the Moderna, AstraZeneca, Janssen, and Novavax COVID-19 vaccine clinical trials, we allocated participants into four groups based on previous-infection status at enrolment and treatment: no previous infection/placebo; previous infection/placebo; no previous infection/vaccine; and previous infection/vaccine. The main outcome was RT-PCR-confirmed COVID-19 >7–15 days (per original protocols) after final study injection. We calculated crude and adjusted efficacy measures. Findings: Previous infection/placebo participants had a 92% decreased risk of future COVID-19 compared to no previous infection/placebo participants (overall hazard ratio [HR] ratio: 0.08; 95% CI: 0.05–0.13). Among single-dose Janssen participants, hybrid immunity conferred greater protection than vaccine alone (HR: 0.03; 95% CI: 0.01–0.10). Too few infections were observed to draw statistical inferences comparing hybrid immunity to vaccine alone for other trials. Vaccination, previous infection, and hybrid immunity all provided near-complete protection against severe disease. Interpretation: Previous infection, any hybrid immunity, and two-dose vaccination all provided substantial protection against symptomatic and severe COVID-19 through the early Delta period. Thus, as a surrogate for natural infection, vaccination remains the safest approach to protection. Funding: National Institutes of Health